THIRD EXTENSION - GRANTED
granted
on 13 Dec 2024
Last Applicant/ Owned by
17th Floor
New York
NY
10022
Serial Number
97425869 filed on 24th May 2022
Registration Number
N/A
Correspondent Address
Tomas M. Casalins
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
KNACK PHARMA
Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions Pharmaceutical preparations for the treatment and prevention of psychological disorders; Pharmaceutical preparations for th Read More
Classification Information
Class [035]
Advertising, Business & Retail Services
Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of psychological disorders; Pharmaceutical preparations for the treatment and prevention of epilepsy disorders; Pharmaceutical preparations for the treatment and prevention of diabetes and diabetic neuropathy; Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases and disorders; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of pain and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of respiratory system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormone disorders and deficiencies; Pharmaceutical preparations for the treatment and prevention of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of nausea and vomiting; Pharmaceutical preparations for the treatment and prevention of AIDS-related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations for the treatment and prevention of depression; Pharmaceutical preparations for the treatment of exposure to toxic agents; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations, namely, injectable contraceptives
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97425869
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Dec 2024 | SOU EXTENSION 3 GRANTED |
| 14th Dec 2024 | SOU EXTENSION 3 FILED |
| 13th Dec 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 18th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Jun 2024 | SOU EXTENSION 2 FILED |
| 18th Jun 2024 | SOU EXTENSION 2 GRANTED |
| 18th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 01st May 2024 | ASSIGNED TO EXAMINER |
| 21st Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |